NCT04621409View on ClinicalTrials.gov

LEAP2 on Postprandial Glucose Metabolism and Food Intake

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Obesity
Interventions
BIOLOGICAL

Liver-enriched antimicrobial peptide 2

IV infusion of LEAP2, approximately 5 hours

BIOLOGICAL

Placebo

IV infusion of saline, approximately 5 hours

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT04621409 - LEAP2 on Postprandial Glucose Metabolism and Food Intake | Biotech Hunter | Biotech Hunter